Showing 1 - 10 of 7,742
Persistent link: https://www.econbiz.de/10010457465
Rights (TRIPS Agreement) and Public Health adopted by the World Trade Organization, we realize that its impact is beyond …
Persistent link: https://www.econbiz.de/10014441903
Persistent link: https://www.econbiz.de/10012433890
and unequal access will lead to an increase in international inequalities, leaving a large part of the world to have …
Persistent link: https://www.econbiz.de/10012496070
without the patent owner's authorization by issuing a compulsory license (CL). In the pharmaceuticals space, governments have … before patent expiry, increasing the supply and reducing the price of patented pharmaceuticals domestically. This paper … evaluates the three primary barriers to employing compulsory licenses for pharmaceuticals underscored by members during TRIPS …
Persistent link: https://www.econbiz.de/10013469578
pharmaceuticals. The US-led developed countries bloc argued in favour of patents for pharmaceuticals amidst opposition from Brazil … form of patents for pharmaceuticals, the developing countries were able to extract some procedural and substantive …
Persistent link: https://www.econbiz.de/10013393634
The COVID-19 crisis intensified decade-long debates on the interaction between intellectual property rights (IPRs), competition law and access to affordable life-saving treatments and vaccines. Compulsory licensing of patented medicines is a tried-and-tested method to expand access, particularly...
Persistent link: https://www.econbiz.de/10014541546
Persistent link: https://www.econbiz.de/10010425136
Persistent link: https://www.econbiz.de/10009302918
Persistent link: https://www.econbiz.de/10003433320